Press release
Postoperative Pain Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2023-2032), Analyzes DelveInsight | Taiwan Liposome Company, Teikoku Pharma USA, Durect, Pfizer, Vivozon
Postoperative Pain Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2023-2032), Analyzes DelveInsight | Taiwan Liposome Company, Teikoku Pharma USA, Durect, Pfizer, Vivozon, Salvat Laboratories, Vertex Pharmaceuticals
DelveInsight's "Postoperative Pain Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding of the Postoperative Pain, historical and forecasted epidemiology as well as the Postoperative Pain market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Postoperative Pain market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Postoperative Pain Market Forecast [https://www.delveinsight.com/sample-request/postoperative-pain-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Some of the key facts of the Postoperative Pain Market Report:
* The Postoperative Pain market size was valued ~USD 2,440 million in 2022 and is anticipated to grow with a significant CAGR during the study period (2019-2032)
* The number of Postoperative Pain incident cases in the 7MM was 77,984,000 in 2022, and by 2032, that number is predicted to rise
* Germany had the most incident cases of postoperative pain among the EU4 nations in 2022 (5,046,000 cases), followed by France
* In Japan, there were 13,335,000 Postoperative Pain event cases in total in 2022, and that number is predicted to rise by 2032
* According to postoperative pain severity, mild, moderate, and severe cases made up 25%, 45%, and 31%, respectively, of all incident cases in the US in 2022
* Further division of the visit-specific distribution into inpatient and outpatient categories resulted in 15,200,000 and 1,469,000 cases of postoperative pain in Japan in 2022, respectively
* According to research done in 2022, mild, moderate, and severe cases of postoperative pain in Germany were found to have severity specific cases of 54%, 27%, and 19%, respectively
* Key Postoperative Pain Companies: Taiwan Liposome Company (TLC), Teikoku Pharma USA, Concentric Analgesics, Salvat Laboratories, Vertex Pharmaceuticals, Oculis, Baudax Bio, Jiangsu HengRui Medicine, Darnitsa Pharma, Adynxx, Inc., Pacira Pharma, Apsen Farmaceutica S.A., Durect, Pfizer, Vivozon, Inc., Grunenthal GmbH, Mallinckrodt, Astellas Pharma Inc, Ferndale Laboratories, Inc., and others
* Key Postoperative Pain Therapies: TLC590, TPU-006, CA-008, SVT-15473, VX-548, OCS-01, N1539, SHR0410, Ketorolac tromethamine, AYX1, EXPAREL, Toragesic Registered , SABER-Bupivacaine, lyrica, VVZ-149, Tapentadol (OS), Percocet, YM177, LMX4, and others
* The Postoperative Pain market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Postoperative Pain pipeline products will significantly revolutionize the Postoperative Pain market dynamics.
Postoperative Pain Overview
Postoperative pain refers to the discomfort or soreness experienced by patients following a surgical procedure. This type of pain occurs as a natural response to tissue injury during surgery and can vary in intensity depending on factors such as the type and extent of surgery, individual pain tolerance, and the presence of underlying health conditions.
Get a Free sample for the Postoperative Pain Market Report
https://www.delveinsight.com/report-store/postoperative-pain-market [https://www.delveinsight.com/report-store/postoperative-pain-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Postoperative Pain Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Postoperative Pain Epidemiology Segmentation:
The Postoperative Pain market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
* Total Prevalence of Postoperative Pain
* Prevalent Cases of Postoperative Pain by severity
* Gender-specific Prevalence of Postoperative Pain
* Diagnosed Cases of Episodic and Chronic Postoperative Pain
Download the report to understand which factors are driving Postoperative Pain epidemiology trends @ Postoperative Pain Epidemiology Forecast [https://www.delveinsight.com/sample-request/postoperative-pain-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Postoperative Pain Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Postoperative Pain market or expected to get launched during the study period. The analysis covers Postoperative Pain market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Postoperative Pain Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Postoperative Pain Therapies and Key Companies
* TLC590: Taiwan Liposome Company (TLC)
* TPU-006: Teikoku Pharma USA
* CA-008: Concentric Analgesics
* SVT-15473: Salvat Laboratories
* VX-548: Vertex Pharmaceuticals
* OCS-01: Oculis
* N1539: Baudax Bio
* SHR0410: Jiangsu HengRui Medicine
* Ketorolac tromethamine: Darnitsa Pharma
* AYX1: Adynxx, Inc.
* EXPAREL: Pacira Pharma
* Toragesic Registered : Apsen Farmaceutica S.A.
* SABER-Bupivacaine: Durect
* lyrica: Pfizer
* VVZ-149: Vivozon, Inc.
* Tapentadol (OS): Grunenthal GmbH
* Percocet: Mallinckrodt
* YM177: Astellas Pharma Inc
* LMX4: Ferndale Laboratories, Inc.
Discover more about therapies set to grab major Postoperative Pain market share @ Postoperative Pain Treatment Market [https://www.delveinsight.com/sample-request/postoperative-pain-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Postoperative Pain Market Strengths
* Growing research and development and rising awareness about multimodal analgesia among clinicians and patients are increasing the demand for better diagnosis and treatment options for postoperative pain, and drugs in the higher phases of development like APP13007, OCS-01, TLC590, VX-548 are likely to strengthen the overall market
* Upcoming therapies are majorly non-opioids which are as effective, and this would reduce opioid dependence and other safety concerns associated with the current opioid medications
Postoperative Pain Market Opportunities
* Increased public awareness creates a lucrative opportunity for the innovation of therapeutics to drive this market
* Multimodal treatments can be prescribed to reduce the dependency on single-modal treatment. Launching such products will increase the potential ability to treat postoperative pain
* Increasing patient population, government findings, and a better research agenda will provide great research and development opportunities
Scope of the Postoperative Pain Market Report
* Study Period: 2019-2032
* Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
* Key Postoperative Pain Companies: Taiwan Liposome Company (TLC), Teikoku Pharma USA, Concentric Analgesics, Salvat Laboratories, Vertex Pharmaceuticals, Oculis, Baudax Bio, Jiangsu HengRui Medicine, Darnitsa Pharma, Adynxx, Inc., Pacira Pharma, Apsen Farmaceutica S.A., Durect, Pfizer, Vivozon, Inc., Grunenthal GmbH, Mallinckrodt, Astellas Pharma Inc, Ferndale Laboratories, Inc., and others
* Key Postoperative Pain Therapies: TLC590, TPU-006, CA-008, SVT-15473, VX-548, OCS-01, N1539, SHR0410, Ketorolac tromethamine, AYX1, EXPAREL, Toragesic Registered , SABER-Bupivacaine, lyrica, VVZ-149, Tapentadol (OS), Percocet, YM177, LMX4, and others
* Postoperative Pain Therapeutic Assessment: Postoperative Pain current marketed and Postoperative Pain emerging therapies
* Postoperative Pain Market Dynamics: Postoperative Pain market drivers and Postoperative Pain market barriers
* Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
* Postoperative Pain Unmet Needs, KOL's views, Analyst's views, Postoperative Pain Market Access and Reimbursement
To know more about Postoperative Pain companies working in the treatment market, visit @ Postoperative Pain Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/sample-request/postoperative-pain-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1. Postoperative Pain Market Report Introduction
2. Executive Summary for Postoperative Pain
3. SWOT analysis of Postoperative Pain
4. Postoperative Pain Patient Share (%) Overview at a Glance
5. Postoperative Pain Market Overview at a Glance
6. Postoperative Pain Disease Background and Overview
7. Postoperative Pain Epidemiology and Patient Population
8. Country-Specific Patient Population of Postoperative Pain
9. Postoperative Pain Current Treatment and Medical Practices
10. Postoperative Pain Unmet Needs
11. Postoperative Pain Emerging Therapies
12. Postoperative Pain Market Outlook
13. Country-Wise Postoperative Pain Market Analysis (2019-2032)
14. Postoperative Pain Market Access and Reimbursement of Therapies
15. Postoperative Pain Market Drivers
16. Postoperative Pain Market Barriers
17. Postoperative Pain Appendix
18. Postoperative Pain Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=postoperative-pain-market-is-predicted-to-exhibit-remarkable-growth-during-the-forecast-period-20232032-analyzes-delveinsight-taiwan-liposome-company-teikoku-pharma-usa-durect-pfizer-vivozon]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Postoperative Pain Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2023-2032), Analyzes DelveInsight | Taiwan Liposome Company, Teikoku Pharma USA, Durect, Pfizer, Vivozon here
News-ID: 3475072 • Views: …
More Releases from ABNewswire
98% Consistency, 0 Staff: Anno Robot Redefines Airport Coffee in 60 Countries
As millions of travellers rush through terminals worldwide, one constant complaint has finally been solved: bad airport coffee served slowly by exhausted staff. Shenzhen-based Anno Robot [https://www.coffeerobotsanno.com/] has quietly eliminated both problems with fully robotic kiosks that deliver 98% brew-to-brew consistency and require zero human baristas. By November 2025, these AI-powered stations are operating in airports and high-traffic hubs across more than 60 countries, marking a turning point for the…
FAXVIN Unveils Enhanced CarRank, a 0-100 Single-Score Summary That Makes Used-Ca …
Updated methodology brings additional partner data and refined signal weighting so shoppers and dealers can rank and compare vehicles in seconds.
WALNUT, Calif. - Nov. 19, 2025 - FAXVIN today announced a significant update to CarRank, its 0-100 vehicle-history metric designed to help shoppers and dealers compare used cars at a glance. The latest release incorporates additional data sources and methodology refinements that improve how risk signals are weighted across title…
Global Pro AV Market Surges Toward USD 127.31 Billion by 2030, Led by Sony, Sams …
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2025-2030.
According to Arizton research, the global pro AV market [https://www.arizton.com/market-reports/pro-av-market] was valued at USD 90.00 billion in 2024 and is projected to reach USD 127.31 billion by 2030, growing at a CAGR of 5.95% during the forecast period.
Explore the Full Market Insights: https://www.arizton.com/market-reports/pro-av-market
Report Summary:
Market Size (2030): USD 127.31 Billion
Market Size (2024): USD 90.00 Billion
CAGR (2024-2030): 5.95%
Historic…
Redway Power Launches High-Capacity 51.2V 420Ah Lithium Forklift Battery for Nex …
Redway Power, a leading OEM lithium battery manufacturer, proudly announces the launch of its latest innovation: the 51.2V 420Ah Lithium Forklift Battery [https://www.redwaypower.com/product/48v-420ah-forklift-lithium-battery/]. Designed for modern industrial operations, this next-generation battery combines high capacity, advanced safety features, and customizable OEM/ODM solutions to revolutionize warehouse productivity and material handling efficiency.
Introducing Next-Generation Power for Forklifts
The new 51.2V 420Ah battery is engineered to deliver exceptional energy efficiency and durability. With a nominal energy…
More Releases for Postoperative
Postoperative Acute Pain Market Trends, Treatments, and Global Forecast
Postoperative acute pain (POAP) remains one of the most significant challenges in clinical care, affecting nearly 80% of patients after surgery. Poorly managed pain can lead to complications such as delayed recovery, prolonged hospital stays, readmissions, and higher healthcare costs. Traditionally, opioid analgesics have been the cornerstone of treatment, but rising concerns around opioid dependency and adverse effects are fueling demand for safer, multimodal pain management approaches.
Download Full PDF Sample…
Postoperative Pain Therapeutics Market Innovations and Trends for 2032
The Postoperative Pain Therapeutics market has become an essential sector within the healthcare industry, particularly in the wake of increasing surgical procedures and the subsequent need for effective pain management solutions. This market encompasses a wide range of therapeutics designed to alleviate pain following surgical interventions, ensuring patient comfort and satisfaction during recovery. With a focus on improving patient outcomes, the postoperative pain therapeutics market has seen significant advancements, driven…
Postoperative Pain Therapeutics Market Analysis and Forecast (2024-2032)
The introduction serves as the foundational section of our analysis. It aims to provide a comprehensive overview of the Postoperative Pain Therapeutics Market, emphasizing its significance and the purpose of the analysis.
The Postoperative Pain Therapeutics Market plays a pivotal role in the healthcare industry. It addresses the critical need for effective pain management following surgical procedures, contributing to patient comfort and recovery. This market has witnessed substantial growth due to…
Postoperative Pain Therapeutics Market: An In-Depth Analysis
In the ever-evolving landscape of healthcare, the Postoperative Pain Therapeutics Market has emerged as a significant player. This market, valued at USD 0.88 billion in 2023, is driven by various factors such as the production and commercialization of new drugs, increased research and development activities, rising health concerns, enhanced diagnostics facilities, and a growing global population. With a projected compound annual growth rate (CAGR) of 9.3% between 2024 and 2032,…
Postoperative Nausea and Vomiting Management Market Rising focus on patient comf …
Global Postoperative Nausea and Vomiting Management Market Overview:
The Postoperative Nausea and Vomiting Management market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others.
In recent years, the Postoperative Nausea and Vomiting Management market has experienced significant growth, driven by factors such as increasing consumer demand,…
Prevention and management of postoperative endophthalmitis
The decisive criterion of postoperative endophthalmitis after cataract operations or intravitreal injections is the contamination of the operating area and the instruments / implants with pathogens during the surgical procedure. In traditional operating theaters, the "sterility" is very limited and only given directly under the supply air ceiling. However, the surgical field is almost completely shielded from the ultra-clean air by the surgical microscope and the surgeon's head, so that…
